UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
To evaluate changes in coagulation (blood clotting) factors and platelet function in multiple
myeloma participants undergoing VELCADE treatment for the first time.